You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ovarian/Endometrial Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Beijing (HS-20089)

Not yet recruiting
  • Ovarian Cancer
  • +3 more
  • Beijing, Beijing, China
    Lingying Wu
Aug 22, 2023

Ovarian Cancer and Endometrial Cancer for

Not yet recruiting
  • Ovarian Cancer
  • +2 more
  • Artificial-Intelligence Based Screening Tools
  • Pathology analysis
  • Makassar, South Sulawesi, Indonesia
  • +1 more
Jan 14, 2023

Ovarian Cancer, Malignant Tumor of Uterus Trial in New York (Sacituzumab, Cisplatin)

Not yet recruiting
  • Ovarian Cancer
  • Malignant Neoplasm of Uterus
  • New York, New York
    Icahn School of Medicine at Mount Sinai Division of Hematology a
Sep 14, 2023

Ovarian Tumors, Sarcopenia Trial in Chambéry (Sarcopenia diagnostic test)

Recruiting
  • Ovarian Neoplasms
  • Sarcopenia
  • Sarcopenia diagnostic test
  • Chambéry, Savoie, France
    Centre Hospitalier Metropole Savoie
Apr 17, 2023

Medical Imaging in Gynecological Cancer (PRODIGYN)

Not yet recruiting
  • Cervix Cancer
  • +2 more
  • FDG-PET/CT and FDG-PET/MRI
  • (no location specified)
May 2, 2023

Endometrial Cancer, Ovarian Cancer Trial in Sherbrooke (Loperamide Pill, hyoscine-n-butylbromide)

Recruiting
  • Endometrial Cancer
  • Ovarian Cancer
  • Sherbrooke, Quebec, Canada
    Centre de recherche du CHUS
Oct 31, 2022

Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma, Recurrent Endometrial Endometrioid

Not yet recruiting
  • Recurrent Endometrial Carcinoma
  • +8 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +7 more
  • (no location specified)
Jul 15, 2023

Ovary Cancer, Endometrial Cancer, Uterine Cancer Trial in Chicago (FAST Intervention)

Not yet recruiting
  • Ovary Cancer
  • +2 more
  • FAST Intervention
  • Chicago, Illinois
    Northwestern Memorial Hospital
Aug 4, 2023

Ovarian Cancer, Endometrial Cancer, Recurrent Ovarian Cancer Trial (BKM120, Nabpaclitaxel)

Withdrawn
  • Ovarian Cancer
  • +3 more
  • (no location specified)
Jul 27, 2022

Ovarian Cancer, Endometrial Cancer, Cervix Cancer Trial in Oklahoma City (SHetA2)

Recruiting
  • Ovarian Cancer
  • +2 more
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center
Jul 7, 2022

Platinum-resistant Ovarian Cancer, Endometrial Adenocarcinoma, Urothelial Carcinoma Trial in Canton (ACR-368, Gemcitabine,

Recruiting
  • Platinum-resistant Ovarian Cancer
  • +2 more
  • Mobile, Alabama
  • +7 more
Jan 24, 2023

Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, Endometrial Adenocarcinoma Trial in Houston (Copanlisib,

Recruiting
  • Deleterious BRCA1 Gene Mutation
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 23, 2022

Ovarian Cancer, Endometrial Cancer, Peritoneal Cancer Trial in Augusta (genetic testing, Survey Administration)

Not yet recruiting
  • Ovarian Cancer
  • +2 more
  • genetic testing
  • Survey Administration
  • Augusta, Georgia
    Georgia Cancer Center at Augusta University
Oct 27, 2022

Metastatic Endometrial Carcinoma, Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma Trial (Biopsy, Biospecimen

Not yet recruiting
  • Metastatic Endometrial Carcinoma
  • +7 more
  • Biopsy
  • +5 more
  • (no location specified)
Jan 18, 2023

Ovarian Cancer, Ovarian Carcinoma, Ovarian Cancer Stage IV Trial in Boston (Exercise, Attention Control)

Recruiting
  • Ovarian Cancer
  • +6 more
  • Exercise
  • Attention Control
  • Boston, Massachusetts
    Dana Farber Cancer Institute
May 4, 2022

Gynecologic Cancer, Gynecologic Tumor, Ovarian Cancer Trial in Copenhagen (Nurse-led consultations based on electronic

Recruiting
  • Gynecologic Cancer
  • +3 more
  • Nurse-led consultations based on electronic patient-reported outcomes
  • Copenhagen, Denmark
    Copenhagen University Hospital, Rigshospitalet
Jan 23, 2023

Phenotypic Spectrum of CTCs in Tumors of Female Reproductive

Completed
  • Breast Cancer
  • +2 more
  • Taking 5 ml of venous blood at different time intervals
  • Taking 5 ml EDTA-stabilized ascitic fluid sampled during laparoscopy if any
  • Tomsk, Tomskaya Oblast, Russian Federation
    Evgeniya Kaigorodova
Jan 24, 2023

Renal Cell Carcinoma, Urothelial Carcinoma, Cervical Cancer Trial in Shanghai (SHR-1210, Famitinib)

Recruiting
  • Renal Cell Carcinoma
  • +4 more
  • Shanghai, Shanghai, China
    Huadong Hospital Affiliated to Fudan University
Jun 30, 2022

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

Recruiting
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +6 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
May 17, 2022

Gynecologic Cancer, Cervical Cancer, Endometrial Cancer Trial in Taoyuan City (Hyperpolarized 13C-Pyruvate injection)

Not yet recruiting
  • Gynecologic Cancer
  • +3 more
  • Hyperpolarized 13C-Pyruvate injection
  • Taoyuan City, Guishan District, Taiwan
    Chang Gung Memorial Hospital
Apr 5, 2023

Fallopian Tube Carcinoma, Recurrent Ovarian Cancer, Primary Peritoneal Carcinoma Trial in Columbus (Lenvatinib Mesylate,

Completed
  • Fallopian Tube Carcinoma
  • +3 more
  • Lenvatinib Mesylate
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Apr 5, 2022

Recurrent Gynecological Cancer, Metastatic Cervical Cancer, Metastatic Ovarian Cancer Trial in Boston (Durvalumab, Tremelimumab,

Terminated
  • Recurrent Gynecological Cancer
  • +10 more
  • Boston, Massachusetts
    Martin King
Oct 4, 2022

Advanced Solid Tumor, Advanced Cancer, Advanced Carcinoma Trial (AMT-151)

Not yet recruiting
  • Advanced Solid Tumor
  • +18 more
  • (no location specified)
Aug 10, 2022

Gynecologic Cancer, Ovary Cancer, Pancreatic Cancer Trial in Houston (Free genetic testing and counseling group, IGNITE-TX

Not yet recruiting
  • Gynecologic Cancer
  • +8 more
  • Free genetic testing and counseling group
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Center
Jan 11, 2023

Immunotherapy-related CRP Kinetics in Metastatic Gynecological

Recruiting
  • Gynecological Malignancies
  • +4 more
    • Tuebingen, Germany
      Department of Women's Health
    Jun 13, 2023